Peptide InjectionsAI
Emerging evidence

AOD-9604

Peptide therapy: benefits, side effects, cost and protocols

16 aa / 1,815.1 g/mol / CID 71300630 / hGH(177-191) with N-terminal Tyr
YLRIVQCRSVEGSCGF

AOD-9604 is a lipolytic 16-amino acid peptide fragment of human growth hormone, consisting of HGH residues 176-191. Initial human trials showed it retains the lipolytic properties of growth hormone without stimulating IGF-1 production. Its development was terminated in 2007 after later studies failed to demonstrate sufficient lipolytic effect.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Banned from Compounding March 2024 Removed from compounding nomination list. HGH fragment not eligible for compounding.
Evidence
Emerging Evidence

Who AOD-9604 is usually considered for

  • Fat metabolism
  • Lipolysis support
  • Body composition
  • Primarily animal or early-phase data

How AOD-9604 works

HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.

Key studies

16 papers on PubMed

  1. 01

    Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions

    J Am Acad Orthop Surg Glob Res Rev

  2. 02

    Therapeutic peptides reviewed for orthopaedic applications and future directions

  3. 03

    Analytical approaches for the detection of emerging therapeutics and non-approved drugs in human doping controls

    J Pharm Biomed Anal

  4. 04

    Review of analytical methods for detecting emerging therapeutics and non-approved drugs in doping controls

  5. 05

    Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions

    Expert Rev Proteomics / Expert Rev Proteomics

  6. 06

    Review of current methods and future directions for detecting peptidic drugs in sports doping

  7. 07

    Obesity drugs in clinical development

    Curr Opin Investig Drugs / Curr Opin Investig Drugs

  8. 08

    Survey of obesity drug candidates and therapeutics in clinical development pipeline

  9. 09

    Gateways to clinical trials

    Methods Find Exp Clin Pharmacol / Methods Find Exp Clin Pharmacol

  10. 10

    Gateway approaches to clinical trial design and methodology

AOD-9604 compound data

C78H123N23O23S2
1815.1 g/mol
71300630 ↗
(2S)-2-[[2-[[(4R,7S,13S,16S,19S,22S,25R)-25-[[(2S)-5-amino-2-[[(2S)-2-[[(2S,3S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-4-methyl-pentanoyl]amino]-5-guanidino-pentanoyl]amino]-3-methyl-pentanoyl]amino]-3-methyl-butanoyl]amino]-5-oxo-pentanoyl]amino]-13-(2-carboxyethyl)-22-(3-guanidinopropyl)-7,19-bis(hydroxymethyl)-16-isopropyl-6,9,12,15,18,21,24-heptaoxo-1,2-dithia-5,8,11,14,17,20,23-heptazacyclohexacosane-4-carbonyl]amino]acetyl]amino]-3-phenyl-propanoic acid

AOD-9604 questions

What is AOD-9604?

AOD-9604 is a modified fragment of human growth hormone (HGH) specifically researched for its potential lipolytic (fat-burning) effects without the growth-promoting properties of full HGH.

How does AOD-9604 work?

HGH fragment (amino acids 177-191) that may stimulate lipolysis and inhibit lipogenesis without affecting blood sugar or growth.

Is AOD-9604 legal to buy?

AOD-9604 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy AOD-9604?

AOD-9604 has mixed availability - it can be found through both compounding pharmacies (with prescription) and research suppliers.

What category does AOD-9604 belong to?

AOD-9604 is primarily classified as a weight loss & metabolic peptide. Peptides researched for their effects on weight management, fat metabolism, appetite regulation, and metabolic enhancement. This category includes GLP-1 agonists, dual/triple agonists, and other metabolic peptides.

What are the research benefits of AOD-9604?

AOD-9604 has been studied for: Fat metabolism, Lipolysis support, Body composition. HGH fragment focused on lipolysis.

AOD-9604 in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering AOD-9604?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz